Rapid vasomotor symptom relief

In a clinical trial, women taking ACTIVELLA® 0.5 mg/0.1 mg achieved rapid relief from moderate to severe vasomotor symptoms within 3 to 4 weeks.1,8 By week 8, the mean number of moderate to severe hot flashes had fallen from 70.9 at baseline to 17.4 in the ACTIVELLA® 0.5 mg/0.1 mg treatment arm versus placebo, which fell from 70.0 to 38.2.9

ACTIVELLA® 0.5 mg/0.1 mg - Rapid relief from moderate to severe vasomotor symptoms

PreviousNext

Important Safety Information

REFERENCES:

  • 1. ACTIVELLA® [package insert]. Princeton, NJ: Novo Nordisk Inc; 2007.
  • 8. Panay N, Ylikorkala O, Archer DF, Gut R, Lang E. Ultra-low-dose estradiol and norethisterone acetate: effective menopausal symptom relief. Climacteric. 2007;10:120-131.
  • 9. Data on file. CTR. Novo Nordisk Inc, Princeton, NJ. Trial ID: ALD-1537.